Outcome of Board Meeting for the quarter and year ended March 31, 2026
HEALTHX · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Health X Platform Ltd (formerly Sastasundar Ventures Ltd) announced Q4 and FY2026 results. Consolidated revenue grew 18.7% to Rs 1,31,927 Lakhs, with net profit at Rs 144.73 Lakhs versus a massive loss of Rs 12,274 Lakhs in FY2025, largely due to exceptional items. However, standalone operations remain deeply loss-making with Rs 95.12 Lakhs loss for FY2026 (vs Rs 71.37 Lakhs loss). The company renamed from Sastasundar Ventures to Health X Platform Ltd during the year. Statutory auditors JKVS & Co issued an unmodified opinion but flagged a material uncertainty regarding going concern for step-down subsidiary Genu Path Labs Ltd due to accumulated losses. The board reappointed M/s Priya Gupta & Co as internal auditor for FY2026-27.
Consolidated turnaround from huge loss to profit is positive, but the standalone losses, going concern warning for a subsidiary, and unmodified auditor opinion flagging subsidiary issues suggest underlying business challenges that investors should monitor carefully.